Norges Bank Portfolio holdings
Norges Bank, established in 1816 and headquartered in Oslo, Norway, serves as the central bank of Norway, responsible for monetary policy, issuing the Norwegian krone, and maintaining financial stability. Beyond its traditional central banking role, it oversees the management of the Government Pension Fund Global (often called the Norwegian Oil Fund), one of the world’s largest sovereign wealth funds, valued at over $1 trillion, which invests Norway’s oil and gas revenues in global equities, bonds, and real estate. The fund’s investment arm, Norges Bank Investment Management (NBIM), operates independently to ensure long-term wealth preservation for future generations, emphasizing sustainable and ethical investing practices. With its dual role, Norges Bank uniquely blends central banking duties with stewardship of a massive global investment portfolio.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$1.73B |
| 2 |
Synchrony
SYF
|
$308M |
| 3 |
Nike
NKE
|
$297M |
| 4 |
Hewlett Packard
HPE
|
$258M |
| 5 |
Amazon
AMZN
|
$209M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$1.63B |
| 2 |
Mastercard
MA
|
$391M |
| 3 |
Chubb
CB
|
$270M |
| 4 |
Oracle
ORCL
|
$246M |
| 5 |
Cummins
CMI
|
$203M |
Sector Composition
| 1 | Financials | 19.23% |
| 2 | Healthcare | 14.67% |
| 3 | Technology | 13.73% |
| 4 | Consumer Discretionary | 9.87% |
| 5 | Communication Services | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Home Depot
HD
$405B
| $1.5B | 0.75% | 11,341,516 +239,460 | +2% | +$31.7M |
|
27
Merck
MRK
$210B
| $1.44B | 0.72% | 27,322,627 +625,195 | +2% | +$33M |
|
28
Visa
V
$683B
| $1.33B | 0.66% | 17,204,413 -182,803 | -1% | -$14.2M |
|
29
Citigroup
C
$178B
| $1.32B | 0.66% | 25,523,671 +1,989,113 | +8% | +$103M |
|
30
Cisco
CSCO
$274B
| $1.31B | 0.65% | 48,412,860 +1,854,528 | +4% | +$50.4M |
|
31
Gilead Sciences
GILD
$140B
| $1.31B | 0.65% | 12,928,294 +436,388 | +3% | +$44.2M |
|
32
IBM
IBM
$227B
| $1.25B | 0.62% | 9,114,980 +133,951 | +1% | +$18.4M |
|
33
PepsiCo
PEP
$204B
| $1.25B | 0.62% | 12,502,993 +133,170 | +1% | +$13.3M |
|
34
UnitedHealth
UNH
$281B
| $1.07B | 0.53% | 9,129,005 +267,494 | +3% | +$31.5M |
|
35
Amgen
AMGN
$155B
| $1.07B | 0.53% | 6,597,844 +122,225 | +2% | +$19.8M |
|
|
36
Oracle
ORCL
$635B
| $1.07B | 0.53% | 29,229,930 -6,737,393 | -19% | -$246M |
|
37
Berkshire Hathaway Class A
BRK.A
$1.09T
| $1.01B | 0.5% | 5,129 +86 | +2% | +$17M |
|
38
McDonald's
MCD
$224B
| $1.01B | 0.5% | 8,511,984 +284,257 | +3% | +$33.6M |
|
39
Hilton Worldwide
HLT
$64.9B
| $989M | 0.49% | 46,226,359 +1,967,231 | +4% | +$42.1M |
|
|
40
Berkshire Hathaway Class B
BRK.B
$1.09T
| $971M | 0.48% | 7,353,327 -487,638 | -6% | -$64.4M |
|
41
CVS Health
CVS
$92.8B
| $955M | 0.47% | 9,770,372 +52,815 | +0.5% | +$5.16M |
|
|
AGN
42
DELISTED
Allergan plc
AGN
| $948M | 0.47% | 3,032,200 -242,352 | -7% | -$75.7M |
|
43
3M
MMM
$82.8B
| $882M | 0.44% | 5,858,227 +290,935 | +5% | +$43.8M |
|
44
Bristol-Myers Squibb
BMY
$96B
| $875M | 0.44% | 12,719,018 +247,481 | +2% | +$17M |
|
45
Schlumberger
SLB
$55B
| $846M | 0.42% | 12,130,988 +1,037,775 | +9% | +$72.4M |
|
46
Ameriprise Financial
AMP
$48.5B
| $843M | 0.42% | 7,919,556 +935,500 | +13% | +$99.6M |
|
47
Medtronic
MDT
$119B
| $841M | 0.42% | 10,934,256 -767,440 | -7% | -$59M |
|
48
AbbVie
ABBV
$372B
| $839M | 0.42% | 14,161,820 +168,244 | +1% | +$9.97M |
|
49
Eli Lilly
LLY
$657B
| $771M | 0.38% | 9,156,064 -307,214 | -3% | -$25.9M |
|
|
50
Mastercard
MA
$538B
| $768M | 0.38% | 7,886,312 -4,011,226 | -34% | -$391M |
|